Efficacy and safety of ivabradine in patients with chronic systolic heart failure according to blood pressure level in SHIFT.
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F14%3A33152244" target="_blank" >RIV/61989592:15110/14:33152244 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1002/ejhf.114" target="_blank" >http://dx.doi.org/10.1002/ejhf.114</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1002/ejhf.114" target="_blank" >10.1002/ejhf.114</a>
Alternative languages
Result language
angličtina
Original language name
Efficacy and safety of ivabradine in patients with chronic systolic heart failure according to blood pressure level in SHIFT.
Original language description
AIMS: Low systolic blood pressure (SBP) is associated with poor outcomes in heart failure and complicates management. In a post hoc analysis, we investigated the efficacy and safety of ivabradine in the SHIFT population divided by tertiles of baseline SBP. METHODS AND RESULTS: The analysis comprised 2110 patients with SBP {115 mmHg, 1968 with 115? SBP {130 mmHg, and 2427 with SBP ?130 mmHg. Patients with low SBP were younger, had lower ejection fraction, and were less likely to be at target beta-blockerdose than patients in the other SBP groups. Ivabradine was associated with a similar relative risk reduction of the composite outcome in the three SBP groups [SBP {115 mmHg, hazard ratio (HR) = 0.84, 95% confidence interval (CI) 0.72-0.98; 115? SBP {130mmHg, HR = 0.86, 95% CI 0.72 to 1.03; SBP ?130 mmHg, HR = 0.77, 95% CI 0.66 to 0.92; P interaction = 0.68]. Similar results were found for cardiovascular mortality (P interaction = 0.91), hospitalization because of heart failure (P inter
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FA - Cardiovascular diseases including cardio-surgery
OECD FORD branch
—
Result continuities
Project
—
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Others
Publication year
2014
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
European Journal of Heart Failure
ISSN
1879-0844
e-ISSN
—
Volume of the periodical
16
Issue of the periodical within the volume
7
Country of publishing house
GB - UNITED KINGDOM
Number of pages
7
Pages from-to
810-816
UT code for WoS article
000339094200015
EID of the result in the Scopus database
—